The Social Mission of Prioritizing the Preservation of Patients’ Lives and Relationships of Trust
First written in FY2016. 28 of 29 entries say "Restated". Latest entry: FY2026-H1.
1 other company's latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「We believe that it remains essential to fulfill our social mission of ensuring a stable supply of pharmaceuticals while strengthening our management foundation.」
We continue to pursue the basic policy of balancing the social mission of ensuring a stable supply of pharmaceuticals with strengthening our management foundation. - FY2024RestatedAnnual report
「Under these circumstances, we will make further efforts to enhance corporate value so that, after fulfilling our social mission of ensuring a stable supply, we can also strengthen our management foundation and continue to earn the trust of all stakeholders.」
We continue to pursue the basic policy of enhancing corporate value by balancing stable supply, strengthening our management foundation and maintaining the trust of stakeholders. - FY2024-Q3RestatedAnnual report
「We believe that it remains essential to fulfill our social mission of ensuring a stable supply of pharmaceuticals while strengthening our management foundation.」
We continue to pursue the basic policy of balancing the social mission of ensuring a stable supply of pharmaceuticals with strengthening our management foundation. - FY2024-Q2RestatedAnnual report
「We believe that it remains essential to fulfill our social mission of ensuring a stable supply of pharmaceuticals while strengthening our management foundation.」
We continue to pursue the basic policy of balancing the social mission of ensuring a stable supply of pharmaceuticals with strengthening our management foundation. - FY2024-Q1RestatedAnnual report
「We believe that it remains essential to fulfill our social mission of ensuring a stable supply of pharmaceuticals while strengthening our management foundation.」
We continue to pursue the basic policy of balancing the social mission of ensuring a stable supply of pharmaceuticals with strengthening our management foundation. - FY2023-Q3RestatedAnnual report
「We believe that it remains essential to fulfill our social mission of ensuring a stable supply of pharmaceuticals while strengthening our management foundation.」
We continue to pursue the basic policy of balancing the social mission of ensuring a stable supply of pharmaceuticals with strengthening our management foundation. - FY2023-Q2RestatedAnnual report
「We believe that it remains essential to fulfill our social mission of ensuring a stable supply of pharmaceuticals while strengthening our management foundation.」
We continue to pursue the basic policy of balancing the social mission of ensuring a stable supply of pharmaceuticals with strengthening our management foundation. - FY2023-Q1RestatedAnnual report
「We believe that it remains essential to fulfill our social mission of ensuring a stable supply of pharmaceuticals while strengthening our management foundation.」
We have reaffirmed our basic commitment to pursuing both the social mission of ensuring a stable supply of pharmaceuticals and strengthening our management foundation. - FY2022RestatedAnnual report
「We are deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and have made responding to the expectations of shareholders and other stakeholders our basic management policy.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and responding to the expectations of stakeholders. - FY2022-Q2RestatedAnnual report
「We believe that it remains essential to fulfill our social mission of ensuring a stable supply of pharmaceuticals while strengthening our management foundation.」
We continue to pursue both the social mission of ensuring a stable supply of pharmaceuticals and strengthening our management foundation. - FY2021RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2021-Q3RestatedAnnual report
「We believe that it remains essential to fulfill our social mission of ensuring a stable supply of pharmaceuticals while strengthening our management foundation.」
We have reaffirmed our commitment to balancing the social mission of ensuring a stable supply of pharmaceuticals with strengthening our management foundation. - FY2021-Q2RestatedAnnual report
「We believe that it remains essential to fulfill our social mission of ensuring a stable supply of pharmaceuticals while strengthening our management foundation.」
We have reaffirmed our commitment to balancing the social mission of ensuring a stable supply of pharmaceuticals with strengthening our management foundation. - FY2021-Q1RestatedAnnual report
「We believe that it remains essential to fulfill our social mission of ensuring a stable supply of pharmaceuticals while strengthening our management foundation.」
We have reaffirmed our commitment to pursuing both the social mission of ensuring a stable supply of pharmaceuticals and strengthening our management foundation. - FY2020-Q3RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2020-Q2RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2020-Q1RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2019RestatedAnnual report
「We are deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2019-Q3RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2019-Q2RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2019-Q1RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2018RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2018-Q3RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2018-Q1RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2017RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2017-Q3RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2017-Q2RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2017-Q1RestatedAnnual report
「We are also deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
We continue to emphasize our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders. - FY2016First statedAnnual report
「We are deeply aware of our social mission and responsibilities as a pharmaceutical company, rigorously comply with laws and regulations based on high ethical standards, and promote management focused on enhancing corporate value by working to strengthen relationships of trust with shareholders and other stakeholders.」
Our basic management stance for enhancing corporate value emphasizes our social mission as a pharmaceutical company, ethical standards, compliance with laws and regulations, and relationships of trust with stakeholders.